Publication | Open Access

Response to neoadjuvant immune checkpoint inhibitors and chemotherapy in Chinese patients with esophageal squamous cell carcinoma: the role of tumor immune microenvironment

Tumor Immune MicroenvironmentEsophageal CancerCancer ImmunosurveillanceMedicineImmunologyTumor ImmunityPathologyImmune Checkpoint InhibitorImmunotherapyOncologyTumor MicroenvironmentTumor BiologyChinese Patients